Articles

2026

  • Maddali MV, Pugashetti JV, Pienkos SM, Moore AR, Konkol SB, Kim JS, Ma SF, Newton CA, Garcia CK, Adegunsoye A, Strek ME, Chen CH, Linderholm AL, Zemans RL, Moore BB, Wolters PJ, Raj R, Chen JH, Martinez FJ, Noth I, Rogers AJ, Oldham JM. Molecular endotypes predict differential response to immunosuppressant therapy in non-IPF interstitial lung disease. Am J Respir Crit Care Med. 2026 Jan 30:aamag006. doi: 10.1093/ajrccm/aamag006. Epub ahead of print. PMID: 41738192.
  • Oldham J, Molyneaux P, Maddali M, Newton C, Kim J, Konkol S, Pugashetti J, Liu G, Goobie G, Adegunsoye A, Ma SF, Bornstein D, Murray S, Wain L, Saini G, Stewart I, Johnson S, Jenkins G, Strek M, Linderholm A, Chen CH, Fahy W, Zemans R, Moore B, Khanna D, Ryerson C, Flaherty K, Suresh M, Hoffmann-Vold AM, Maher T, Garcia C, Wolters P, Martinez F, Noth I, Smith JA. Prioritizing Therapeutic Targets for Interstitial Lung Disease: A Causal Mediation Analysis. Res Sq [Preprint]. 2026 Feb 5:rs.3.rs-8714555. doi: 10.21203/rs.3.rs-8714555/v1. PMID: 41674845; PMCID: PMC12889817.

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2008-2015

Patents

  • Suppression of allergic lung inflammation and hyperreactivity, U.S. Patent No. 10,314,889, Issued Date: 06/11/2019. Inventors: Wu R, Chen CH, and Lee CC [ISSUED]
  • MPS peptides and use thereof, 1) US Patent No. 10189881, Issued Date: 01/29/2019; 2) International Application No. PCT/US2014/048285, Publication No. WO2015013669, Publication Date: 01/29/2015. Inventors: Wu R and Chen CH [ISSUED]
  • Method for inhibiting Src kinase activity, R.O.C. Patent No. I418360, Issued Date: 12/11/2013. Inventors: Chen JW, Chen CH, Yu SL and Chang CC [ISSUED]
  • MPS modified peptides and use thereof, U.S. Provisional Patent Application No.: 62/849,637, UC case No.: 2019-089, Filed Date: 05/17/2019. Inventors: Chen CH, Wu R, and Yang DC [PENDING]